BACKGROUND & AIMS: Although the cell of origin for pancreatic cancer remains unknown, prior studies have suggested that pancreatic neoplasia may be initiated in progenitor-like cells. To examine the effects of oncogene activation within the pancreatic progenitor pool, we devised a system for real-time visualization of both normal and oncogenic KRAS-expressing pancreatic progenitor cells in living zebrafish embryos. METHODS: By using BAC transgenes under the regulation of ptf1a regulatory elements, we expressed either extended green fluorescent protein (eGFP) alone or eGFP fused to oncogenic KRAS in developing zebrafish pancreas. RESULTS: After their initial specification, normal eGFP-labeled pancreatic progenitor cells were observed to actively migrate away from the forming endodermal gut tube, and subsequently underwent characteristic exocrine differentiation. In contrast, pancreatic progenitor cells expressing oncogenic KRAS underwent normal specification and migration, but failed to differentiate. This block in differentiation resulted in the abnormal persistence of an undifferentiated progenitor pool, and was associated with the subsequent formation of invasive pancreatic cancer. These tumors showed several features in common with the human disease, including evidence of abnormal Hedgehog pathway activation. CONCLUSIONS: These results provide a unique view of the tumor-initiating effects of oncogenic KRAS in a living vertebrate organism, and suggest that zebrafish models of pancreatic cancer may prove useful in advancing our understanding of the human disease.
BACKGROUND & AIMS: Although the cell of origin for pancreatic cancer remains unknown, prior studies have suggested that pancreatic neoplasia may be initiated in progenitor-like cells. To examine the effects of oncogene activation within the pancreatic progenitor pool, we devised a system for real-time visualization of both normal and oncogenic KRAS-expressing pancreatic progenitor cells in living zebrafish embryos. METHODS: By using BAC transgenes under the regulation of ptf1a regulatory elements, we expressed either extended green fluorescent protein (eGFP) alone or eGFP fused to oncogenic KRAS in developing zebrafish pancreas. RESULTS: After their initial specification, normal eGFP-labeled pancreatic progenitor cells were observed to actively migrate away from the forming endodermal gut tube, and subsequently underwent characteristic exocrine differentiation. In contrast, pancreatic progenitor cells expressing oncogenic KRAS underwent normal specification and migration, but failed to differentiate. This block in differentiation resulted in the abnormal persistence of an undifferentiated progenitor pool, and was associated with the subsequent formation of invasive pancreatic cancer. These tumors showed several features in common with the human disease, including evidence of abnormal Hedgehog pathway activation. CONCLUSIONS: These results provide a unique view of the tumor-initiating effects of oncogenic KRAS in a living vertebrate organism, and suggest that zebrafish models of pancreatic cancer may prove useful in advancing our understanding of the human disease.
Authors: Nabeel Bardeesy; Kuang-Hung Cheng; Justin H Berger; Gerald C Chu; Jessica Pahler; Peter Olson; Aram F Hezel; James Horner; Gregory Y Lauwers; Douglas Hanahan; Ronald A DePinho Journal: Genes Dev Date: 2006-11-15 Impact factor: 11.361
Authors: Ralph H Hruban; N Volkan Adsay; Jorge Albores-Saavedra; Miriam R Anver; Andrew V Biankin; Gregory P Boivin; Emma E Furth; Toru Furukawa; Alison Klein; David S Klimstra; Gunter Kloppel; Gregory Y Lauwers; Daniel S Longnecker; Jutta Luttges; Anirban Maitra; G Johan A Offerhaus; Lucía Pérez-Gallego; Mark Redston; David A Tuveson Journal: Cancer Res Date: 2006-01-01 Impact factor: 12.701
Authors: Benjamin S Braun; Joehleen A Archard; Jessica A G Van Ziffle; David A Tuveson; Tyler E Jacks; Kevin Shannon Journal: Blood Date: 2006-05-23 Impact factor: 22.113
Authors: Anna-Pavlina G Haramis; Adam Hurlstone; Yme van der Velden; Harry Begthel; Maaike van den Born; G Johan A Offerhaus; Hans C Clevers Journal: EMBO Rep Date: 2006-01-27 Impact factor: 8.807
Authors: Hatem E Sabaawy; Mizuki Azuma; Lisa J Embree; Huai-Jen Tsai; Matthew F Starost; Dennis D Hickstein Journal: Proc Natl Acad Sci U S A Date: 2006-10-02 Impact factor: 11.205
Authors: David M Langenau; Hui Feng; Stephane Berghmans; John P Kanki; Jeffery L Kutok; A Thomas Look Journal: Proc Natl Acad Sci U S A Date: 2005-04-12 Impact factor: 11.205
Authors: Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson Journal: Cancer Cell Date: 2005-05 Impact factor: 31.743
Authors: Nijaguna B Prasad; Andrew V Biankin; Noriyoshi Fukushima; Anirban Maitra; Surajit Dhara; Abdel G Elkahloun; Ralph H Hruban; Michael Goggins; Steven D Leach Journal: Cancer Res Date: 2005-03-01 Impact factor: 12.701
Authors: Oliver A Kent; Raghu R Chivukula; Michael Mullendore; Erik A Wentzel; Georg Feldmann; Kwang H Lee; Shu Liu; Steven D Leach; Anirban Maitra; Joshua T Mendell Journal: Genes Dev Date: 2010-12-15 Impact factor: 11.361
Authors: Bensheng Ju; Wenbiao Chen; Brent A Orr; Jan M Spitsbergen; Sujuan Jia; Christopher J Eden; Hannah E Henson; Michael R Taylor Journal: Mol Cancer Date: 2015-02-03 Impact factor: 27.401
Authors: In Hye Jung; Ga Lam Leem; Dawoon E Jung; Min Hee Kim; Eun Young Kim; Se Hoon Kim; Hae-Chul Park; Seung Woo Park Journal: Neuro Oncol Date: 2013-01-16 Impact factor: 12.300
Authors: Huiqing Zhan; Jan M Spitsbergen; Wei Qing; Yi Lian Wu; Thomas A Paul; James W Casey; Guor Muor Her; Zhiyuan Gong Journal: Mar Biotechnol (NY) Date: 2010-01-06 Impact factor: 3.619